Cognition Therapeutics (CGTX) Amortizatization of Intangibles (2020 - 2026)
Cognition Therapeutics (CGTX) reported Amortizatization of Intangibles of $57000.0 for Q1 2026, up 5.56% year-over-year from $54000.0 in Q1 2025, and up 21.28% on a QoQ basis from $47000.0 in Q4 2025.
Cognition Therapeutics (CGTX) has 7 years of Amortizatization of Intangibles data on file, last reported at $57000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles rose 5.56% year-over-year to $57000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $195000.0 (up 7.14% YoY) and the FY2025 annual result came in at $192000.0, up 20.75% from the prior year.
- Amortizatization of Intangibles rose to $57000.0 in Q1 2026 per CGTX's latest filing, from $47000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $57000.0 in Q1 2026 and bottomed at $31000.0 in Q1 2024.
- The 5-year median for Amortizatization of Intangibles is $40000.0 (2023), against an average of $42117.6.
- The widest annual swing landed in 2022, when Amortizatization of Intangibles slumped 85.38%; it then jumped 74.19% in 2025.
- Tracing CGTX's Amortizatization of Intangibles over 5 years: stood at $37000.0 in 2022, then climbed by 5.41% to $39000.0 in 2023, then increased by 12.82% to $44000.0 in 2024, then gained by 6.82% to $47000.0 in 2025, then grew by 21.28% to $57000.0 in 2026.
- Per Business Quant, the three latest CGTX Amortizatization of Intangibles figures stand at $57000.0 (Q1 2026), $47000.0 (Q4 2025), and $46000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | 57,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 57,000.00 |
| Mar 31, 2026 | 57,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Dec 31, 2025 | 47,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Sep 30, 2025 | 46,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 45,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Mar 31, 2025 | 54,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Dec 31, 2024 | 44,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Sep 30, 2024 | 43,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Jun 30, 2024 | 41,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Mar 31, 2024 | 31,000.00 |
| Dec 31, 2023 | 39,000.00 |
| Dec 31, 2023 | 39,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Sep 30, 2023 | 40,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Jun 30, 2023 | 38,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Dec 31, 2022 | 37,000.00 |
| Sep 30, 2022 | 38,000.00 |
| Sep 30, 2022 | 38,000.00 |
| Jun 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 39,000.00 |
| Mar 31, 2022 | 38,000.00 |
| Mar 31, 2022 | 38,000.00 |
| Jun 30, 2021 | 92,000.00 |
| Jun 30, 2021 | 92,000.00 |
| Mar 31, 2021 | 260,000.00 |
| Mar 31, 2021 | 260,000.00 |
| Dec 31, 2020 | 246,000.00 |
| Dec 31, 2020 | 246,000.00 |
| Sep 30, 2020 | 228,000.00 |
| Sep 30, 2020 | 228,000.00 |